• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国 1990 年至 2021 年以及 15 年预测的子宫癌负担:系统分析与全球水平的比较。

Burden of uterine cancer in China from 1990 to 2021 and 15-year projection: a systematic analysis and comparison with global levels.

机构信息

Department of Oncology, Yulin First People's Hospital, No. 495 Middle Education Road, Yulin City, 537000, Guangxi Zhuang Autonomous Region, China.

出版信息

Reprod Health. 2024 Oct 10;21(1):144. doi: 10.1186/s12978-024-01882-2.

DOI:10.1186/s12978-024-01882-2
PMID:39390595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11466025/
Abstract

OBJECTIVE

Uterine cancer (UC) is one of the prevalent malignancies in the female reproductive system. Estimating the burden trends of UC is crucial for developing effective prevention strategies at the national level. However, there has been no comprehensive analysis of the UC burden in China. We focused on the evaluation of the burden trends of UC in China over the past 32 years to provide a 15-year projection, comparing it with global levels.

METHODS

Data on incidence, prevalence, mortality, and disability-adjusted life years (DALYs) were extracted from Global Burden of Disease (GBD) 2021 to describe the burden of UC in China. Joinpoint regression analysis was employed to describe the temporal trends of UC in China and globally over the past 32 years. A Bayesian age-period-cohort model was utilized to predict the trends of UC in the next 15 years. Spearman correlation analysis was used to compare the relationship between ASIR, ASPR, ASMR, ASDR, and SDI in UC in China and globally. Changes in ASMR and ASDR in UC caused by high BMI in China and globally from 1990 to 2021 were explored.

RESULTS

In 2021, the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized DALY rate (ASDR) of UC in China were 6.65, 46.52, 1.24, and 37.86 (per 100,000 population) respectively. Compared to 1990, the ASMR and ASDR decreased by 48.63% and 48.15% respectively, while the ASIR and ASPR increased by 17.79% and 37.67% respectively. Globally, the burden of UC followed a similar trend in China, with increasing ASIR and ASPR, and decreasing ASMR and ASDR, although the magnitude of increase and decrease was smaller than in China. Joinpoint regression analysis results showed an overall upward trend in ASIR and ASPR for both China and global UC, while an overall downward trend was observed in ASMR and ASDR. Age-specific analysis revealed that during the period from 1990 to 2021, the age groups with the highest incidence, prevalence, mortality, and DALYs for UC in China generally occurred at earlier ages compared to the global pattern. It is projected that over the next 15 years, the burden of UC in China will continue to increase at a higher rate than the global level. Spearman correlation analysis showed that ASIR and ASPR of UC in China and the world were significantly positively correlated with SDI (p < 0.05), and ASMR and ASDR were significantly negatively correlated with SDI (p < 0.001). High BMI is a risk factor affecting the mortality rate and DALYs of UC in both China and globally, with the increase in ASMR and ASDR due to high BMI being greater in China than globally.

CONCLUSION

The incidence and prevalence burden of UC among Chinese and global women have shown an increasing trend over the past 32 years, while the mortality and DALYs have decreased. The projected burden of UC in China is anticipated to continue rising at a higher rate than the global level over the next 15 years. Given the large population in China, the government needs to strengthen screening and prevention strategies to mitigate the burden of UC.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d284/11466025/e6047ee38992/12978_2024_1882_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d284/11466025/25a499c13050/12978_2024_1882_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d284/11466025/1b27923434db/12978_2024_1882_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d284/11466025/477ec116a207/12978_2024_1882_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d284/11466025/93b381a700b0/12978_2024_1882_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d284/11466025/e6047ee38992/12978_2024_1882_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d284/11466025/25a499c13050/12978_2024_1882_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d284/11466025/1b27923434db/12978_2024_1882_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d284/11466025/477ec116a207/12978_2024_1882_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d284/11466025/93b381a700b0/12978_2024_1882_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d284/11466025/e6047ee38992/12978_2024_1882_Fig5_HTML.jpg
摘要

目的

子宫癌(UC)是女性生殖系统中常见的恶性肿瘤之一。评估 UC 的负担趋势对于在国家层面制定有效的预防策略至关重要。然而,目前还没有对中国 UC 负担的全面分析。我们专注于评估过去 32 年来中国 UC 负担的变化趋势,并与全球水平进行比较,提供 15 年的预测。

方法

从全球疾病负担(GBD)2021 中提取发病率、患病率、死亡率和伤残调整生命年(DALYs)数据,以描述中国 UC 的负担。采用 Joinpoint 回归分析描述过去 32 年来中国和全球 UC 的时间趋势。利用贝叶斯年龄-时期-队列模型预测未来 15 年 UC 的趋势。采用 Spearman 相关分析比较中国和全球 UC 的年龄标准化发病率(ASIR)、年龄标准化患病率(ASPR)、年龄标准化死亡率(ASMR)和年龄标准化伤残调整生命年率(ASDR)之间的关系。探讨了 1990 年至 2021 年中国和全球 BMI 升高对 UC 的 ASMR 和 ASDR 的影响。

结果

2021 年,中国 UC 的年龄标准化发病率(ASIR)、年龄标准化患病率(ASPR)、年龄标准化死亡率(ASMR)和年龄标准化 DALY 率(ASDR)分别为 6.65、46.52、1.24 和 37.86(每 10 万人)。与 1990 年相比,ASMR 和 ASDR 分别下降了 48.63%和 48.15%,而 ASIR 和 ASPR 分别上升了 17.79%和 37.67%。全球 UC 的负担也呈现出与中国相似的趋势,ASIR 和 ASPR 增加,ASMR 和 ASDR 下降,尽管中国的增减幅度较大。Joinpoint 回归分析结果显示,中国和全球 UC 的 ASIR 和 ASPR 呈总体上升趋势,而 ASMR 和 ASDR 呈总体下降趋势。年龄特定分析表明,在 1990 年至 2021 年期间,中国 UC 的发病率、患病率、死亡率和 DALYs 最高的年龄组通常比全球模式更早出现。预计未来 15 年,中国 UC 的负担将以高于全球水平的速度继续增加。Spearman 相关分析表明,中国和全球 UC 的 ASIR 和 ASPR 与 SDI 呈显著正相关(p<0.05),而 ASMR 和 ASDR 与 SDI 呈显著负相关(p<0.001)。高 BMI 是影响中国和全球 UC 死亡率和 DALYs 的一个风险因素,由于 BMI 升高导致的 ASMR 和 ASDR 增加在中国比全球更为显著。

结论

过去 32 年来,中国和全球女性 UC 的发病率和患病率负担呈上升趋势,而死亡率和 DALYs 则呈下降趋势。预计未来 15 年,中国 UC 的负担将以高于全球水平的速度继续增加。鉴于中国庞大的人口,政府需要加强筛查和预防策略,以减轻 UC 的负担。

相似文献

1
Burden of uterine cancer in China from 1990 to 2021 and 15-year projection: a systematic analysis and comparison with global levels.中国 1990 年至 2021 年以及 15 年预测的子宫癌负担:系统分析与全球水平的比较。
Reprod Health. 2024 Oct 10;21(1):144. doi: 10.1186/s12978-024-01882-2.
2
The long-term spatio-temporal trends in burden and attributable risk factors of major depressive disorder at global, regional and national levels during 1990-2019: a systematic analysis for GBD 2019.1990-2019 年全球、地区和国家层面主要抑郁症负担及归因风险因素的长期时空趋势:GBD 2019 的系统分析。
Epidemiol Psychiatr Sci. 2024 May 20;33:e28. doi: 10.1017/S2045796024000295.
3
Analysis and comparison of the trends in burden of rheumatic heart disease in China and worldwide from 1990 to 2019.分析和比较 1990 年至 2019 年期间中国和全球风湿性心脏病负担的趋势。
BMC Cardiovasc Disord. 2023 Oct 24;23(1):517. doi: 10.1186/s12872-023-03552-w.
4
Global trends and regional differences in disease burden of stroke among children: a trend analysis based on the global burden of disease study 2019.全球儿童卒中疾病负担的趋势和区域差异:基于 2019 年全球疾病负担研究的趋势分析。
BMC Public Health. 2023 Oct 27;23(1):2120. doi: 10.1186/s12889-023-17046-z.
5
Burden of esophageal cancer between 2010 and 2019 in Asian countries by geographical region and sociodemographic index: A comparison with global data.2010 年至 2019 年亚洲国家按地理位置和社会人口指数划分的食管癌负担:与全球数据的比较。
Thorac Cancer. 2023 Aug;14(24):2361-2407. doi: 10.1111/1759-7714.15026. Epub 2023 Jul 17.
6
Disparities in the global burden of tracheal, bronchus, and lung cancer from 1990 to 2019.1990年至2019年全球气管、支气管和肺癌负担的差异。
Chin Med J Pulm Crit Care Med. 2023 Mar 28;1(1):36-45. doi: 10.1016/j.pccm.2023.02.001. eCollection 2023 Mar.
7
Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data.2010 年至 2019 年亚洲国家按地理位置和社会人口指数划分的气管、支气管和肺癌的时间趋势,与全球数据比较。
Thorac Cancer. 2023 Jun;14(18):1668-1706. doi: 10.1111/1759-7714.14912. Epub 2023 May 1.
8
Age-period-cohort analysis of global, regional, and national pancreatic cancer incidence, mortality, and disability-adjusted life years, 1990-2019.1990-2019 年全球、地区和国家胰腺癌发病率、死亡率和伤残调整生命年的年龄-时期-队列分析。
BMC Cancer. 2024 Aug 28;24(1):1063. doi: 10.1186/s12885-024-12835-0.
9
Burden of Stomach Cancer Incidence, Mortality, Disability-Adjusted Life Years, and Risk Factors in 204 Countries, 1990-2019: An Examination of Global Burden of Disease 2019.204 个国家 1990-2019 年胃癌发病、死亡、伤残调整生命年及危险因素负担:2019 年全球疾病负担研究
J Gastrointest Cancer. 2024 Jun;55(2):787-799. doi: 10.1007/s12029-023-01005-3. Epub 2024 Jan 24.
10
The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019.在过去、现在和未来全球、区域和国家 2 型糖尿病的负担:对 2019 年全球疾病负担研究的系统分析。
Front Endocrinol (Lausanne). 2023 Jul 14;14:1192629. doi: 10.3389/fendo.2023.1192629. eCollection 2023.

本文引用的文献

1
The global burden of cardiovascular disease attributable to diet high in sugar-sweetened beverages among people aged 60 years and older: an analysis for the global burden of disease study 2019.全球 60 岁及以上人群因饮用高糖含糖饮料导致心血管疾病的负担:2019 年全球疾病负担研究分析。
Front Public Health. 2024 Jul 19;12:1366286. doi: 10.3389/fpubh.2024.1366286. eCollection 2024.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Time trend of global uterine cancer burden: an age-period-cohort analysis from 1990 to 2019 and predictions in a 25-year period.
全球子宫癌负担的时间趋势:1990 年至 2019 年的年龄-时期-队列分析及 25 年内的预测。
BMC Womens Health. 2023 Jul 21;23(1):384. doi: 10.1186/s12905-023-02535-5.
4
The trends in death of primary liver cancer caused by specific etiologies worldwide: results from the Global Burden of Disease Study 2019 and implications for liver cancer management.全球特定病因原发性肝癌死亡趋势:2019 年全球疾病负担研究结果及其对肝癌管理的影响。
BMC Cancer. 2023 Jun 28;23(1):598. doi: 10.1186/s12885-023-11038-3.
5
Sex-related differences in the hypertriglyceridemic-waist phenotype in association with hyperuricemia: a longitudinal cohort study.性别相关的高三酰甘油血症性腰围表型与高尿酸血症的关系:一项纵向队列研究。
Lipids Health Dis. 2023 Mar 11;22(1):38. doi: 10.1186/s12944-023-01795-2.
6
The Global, Regional, and National Uterine Cancer Burden Attributable to High BMI from 1990 to 2019: A Systematic Analysis of the Global Burden of Disease Study 2019.1990年至2019年全球、区域和国家归因于高体重指数的子宫癌负担:全球疾病负担研究2019的系统分析
J Clin Med. 2023 Feb 27;12(5):1874. doi: 10.3390/jcm12051874.
7
Dietary Factors and Endometrial Cancer Risk: A Mendelian Randomization Study.饮食因素与子宫内膜癌风险:一项孟德尔随机化研究。
Nutrients. 2023 Jan 24;15(3):603. doi: 10.3390/nu15030603.
8
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
9
Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020.分析 2006 年至 2020 年中国女性生殖系统恶性肿瘤疾病负担趋势。
BMC Womens Health. 2022 Dec 7;22(1):504. doi: 10.1186/s12905-022-02104-2.
10
Epidemiological Trends and Attributable Risk Burden of Cervical Cancer: An Observational Study from 1990 to 2019.宫颈癌的流行病学趋势和归因风险负担:1990 年至 2019 年的观察性研究。
Int J Clin Pract. 2022 Sep 30;2022:3356431. doi: 10.1155/2022/3356431. eCollection 2022.